Literature DB >> 26403145

[18F]-NaF PET/CT imaging in cardiac amyloidosis.

Axel Van Der Gucht1,2,3,4,5, Arnault Galat6,7,8,9,10, Jean Rosso6,7,8,11, Aziz Guellich6,7,8,9,10, Jérôme Garot12, Diane Bodez6,7,8,9,10, Violaine Plante-Bordeneuve6,7,8,9,13, Luc Hittinger6,7,8,9,10, Jean-Luc Dubois-Randé6,7,8,9,10, Eva Evangelista6,8,11, Myriam Sasanelli6,8,11, Julia Chalaye6,8,11, Michel Meignan6,7,8,11, Emmanuel Itti6,7,8,11,9, Thibaud Damy6,7,8,9,10.   

Abstract

Cardiac amyloidosis (CA) is recognized as a common cause of restrictive cardiomyopathy and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We emphasize the role of [18F]-sodium fluoride (NaF) PET/CT as a potential noninvasive tool to identify and differentiate the transthyretin-related cardiac amyloidosis from the light-chain cardiac amyloidosis. We report cases of a 73-year-old man and a 75-year-old woman followed in our center for congestive heart failure with marked alteration of the left ventricular ejection fraction due to familial transthyretin Val122Ile cardiac amyloidosis and light-chain cardiac amyloidosis, respectively, confirmed on endomyocardial biopsy.

Entities:  

Keywords:  PET/CT; [18F]-NaF; cardiac amyloidosis; protein deposition

Mesh：

Substances：

Year:  2015        PMID： 26403145     DOI： 10.1007/s12350-015-0287-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  5 in total

1.  Uptake of technetium 99m HDP in cardiac amyloidosis.

Authors:  Jan Kulhanek; Assad Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

2.  Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.

Authors:  Andor W J M Glaudemans; Ronald W J van Rheenen; Maarten P van den Berg; Walter Noordzij; Michel Koole; Hans Blokzijl; Rudi A J O Dierckx; Riemer H J A Slart; Bouke P C Hazenberg
Journal:  Amyloid       Date:  2014-01-23       Impact factor: 7.141

3.  Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.

Authors:  Claudio Rapezzi; Candida C Quarta; Pier Luigi Guidalotti; Cinzia Pettinato; Stefano Fanti; Ornella Leone; Alessandra Ferlini; Simone Longhi; Massimiliano Lorenzini; Letizia Bacchi Reggiani; Christian Gagliardi; Pamela Gallo; Caterina Villani; Fabrizio Salvi
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

4.  Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.

Authors:  Arnault Galat; Jean Rosso; Aziz Guellich; Axel Van Der Gucht; Stephane Rappeneau; Diane Bodez; Soulef Guendouz; Claire-Marie Tissot; Luc Hittinger; Jean-Luc Dubois-Randé; Violaine Plante-Bordeneuve; Emmanuel Itti; Michel Meignan; Thibaud Damy
Journal:  Amyloid       Date:  2015-10-14       Impact factor: 7.141

5.  Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.

Authors:  D F Worsley; B C Lentle
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057
  5 in total
  17 in total

Review 1.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

Review 2.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique.

Authors:  Cesia Gallegos; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2017-03-29       Impact factor: 5.952

4.  Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).

Authors:  Björn Pilebro; Sandra Arvidsson; Per Lindqvist; Torbjörn Sundström; Per Westermark; Gunnar Antoni; Ole Suhr; Jens Sörensen
Journal:  J Nucl Cardiol       Date:  2016-09-19       Impact factor: 5.952

Review 5.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

Review 6.  Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?

Authors:  Vincent Algalarrondo; Eve Piekarski; Ludivine Eliahou; Dominique Le Guludec; Michel S Slama; François Rouzet
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

Review 7.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 8.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

9.  Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

Authors:  Christian Gagliardi; Elena Tabacchi; Rachele Bonfiglioli; Stefania Diodato; Cristina Nanni; Pierluigi Guidalotti; Massimiliano Lorenzini; Filippo Lodi; Agnese Milandri; Claudio Rapezzi; Stefano Fanti
Journal:  J Nucl Cardiol       Date:  2016-03-14       Impact factor: 5.952

Review 10.  Recent Advances in Nuclear Cardiology.

Authors:  Won Woo Lee
Journal:  Nucl Med Mol Imaging       Date:  2016-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.